Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Both treatments for alopecia areata showed similar modest effectiveness.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride can treat prostatic haematuria, but its use is controversial.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Understanding where cancer cells come from helps create better prevention and treatment methods.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The guideline offers practical advice for diagnosing and treating Post-COVID/Long-COVID.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.